Intrinsic Clinical Systems Unveils a New Kind of Clinical Trial Management System
Philadelphia, P.A. (PRWEB) November 14, 2016 -- Intrinsic CTMS is a contemporary CTMS with a streamlined interface that integrates with nearly any other clinical system. The tool’s clean design was created to make study management seamless and efficient. The modern, ribbon-based navigation reduces the learning curve to almost nothing.
“We’ve felt the frustration of clinical trial management systems that are overstuffed with needless features,” said Matt Hendricks, Partner at Intrinsic Clinical Systems. “We spent a lot of time getting the user experience right. We’ve heard the industry’s requests for minimal data entry, a simple interface, and a foolproof study management solution.”
Eric Lake, Partner at Intrinsic Clinical Systems commented, “We’ve held the jobs, we’ve done the work, and we’ve made it our mission to make clinical trial management faster, easier, and less painful.”
“The pharma industry is facing new challenges in study complexity which makes this a pivotal time for a more efficient CTMS,” said Matt Kiernan, Partner at Intrinsic Clinical Systems. “Intrinsic CTMS is made for proactive study management and data integration while abandoning all the “extras” that people never use.”
Those interested in learning more about Intrinsic Clinical Systems or upcoming events can visit http://www.IntrinsicCS.com. To request additional information, please contact Eric Lake at (973) 945-4482.
About Intrinsic Clinical Systems:
The Intrinsic Clinical Systems mission is to provide elegant, streamlined tools to simplify all aspects of drug development operations so biopharma companies can thrive in today’s competitive and cost-conscious environment. By building software tools that provide high value without multi-million dollar price tags, Intrinsic products let companies large and small manage and simplify operations by leveraging new technologies.
Eric Lake, Intrinsic Clinical Systems, http://www.intrinsiccs.com/, +1 973-945-4482, [email protected]
Share this article